• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶活性高与肾细胞癌基因组稳定性和DNA倍体相关。

High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.

作者信息

Izumi Hideki, Hara Takahiko, Oga Atsunori, Matsuda Kenji, Sato Yuko, Naito Katsusuke, Sasaki Kohsuke

出版信息

Neoplasia. 2002 Mar-Apr;4(2):103-11. doi: 10.1038/sj.neo.7900205.

DOI:10.1038/sj.neo.7900205
PMID:11896565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1550322/
Abstract

Malignant tumors have telomerase activity, which is thought to play a critical role in tumor growth. However, the relation between telomerase activity and genomic DNA status in tumor cells is poorly understood. In the present study, we examined telomerase activity in 13 clear cell type renal cell carcinomas (CRCCs) with similar clinicopathologic features by telomeric repeat amplification protocol assay (TRAP). Based on TRAP assay results, we divided the CRCCs into two groups: a high telomerase activity group and a low/no telomerase activity group. We then analyzed genomic aberration, DNA ploidy, and telomere status in these two groups by comparative genomic hybridization (CGH), laser scanning cytometry (LSC), and telomere-specific fluorescence in situ hybridization (T-FISH), respectively. CGH showed the high telomerase activity group to have fewer genomic changes than the low/no telomerase activity group, which had many genomic aberrations. Moreover, with LSC, DNA diploid cells were found more frequently in the high telomerase activity group than in the low/no telomerase activity group. In addition, T-FISH revealed strong telomere signal intensity in the high telomerase activity group compared with that of the low/no telomerase activity group. These results suggest that telomerase activity is linked to genomic DNA status and that high telomerase activity is associated with genomic stability, DNA ploidy, and telomere length in CRCC.

摘要

恶性肿瘤具有端粒酶活性,这被认为在肿瘤生长中起关键作用。然而,肿瘤细胞中端粒酶活性与基因组DNA状态之间的关系尚不清楚。在本研究中,我们通过端粒重复序列扩增法(TRAP)检测了13例具有相似临床病理特征的透明细胞型肾细胞癌(CRCC)的端粒酶活性。根据TRAP检测结果,我们将CRCC分为两组:高端粒酶活性组和低/无端粒酶活性组。然后,我们分别通过比较基因组杂交(CGH)、激光扫描细胞术(LSC)和端粒特异性荧光原位杂交(T-FISH)分析了这两组的基因组畸变、DNA倍体和端粒状态。CGH显示,高端粒酶活性组的基因组变化比低/无端粒酶活性组少,后者有许多基因组畸变。此外,通过LSC发现,高端粒酶活性组中DNA二倍体细胞的出现频率高于低/无端粒酶活性组。另外,T-FISH显示,与低/无端粒酶活性组相比,高端粒酶活性组的端粒信号强度更强。这些结果表明,端粒酶活性与基因组DNA状态有关,并且高端粒酶活性与CRCC中的基因组稳定性、DNA倍体和端粒长度相关。

相似文献

1
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.端粒酶活性高与肾细胞癌基因组稳定性和DNA倍体相关。
Neoplasia. 2002 Mar-Apr;4(2):103-11. doi: 10.1038/sj.neo.7900205.
2
Genetic changes and telomerase activity in human renal cell carcinoma.人类肾细胞癌中的基因变化与端粒酶活性
Clin Cancer Res. 1998 Jan;4(1):197-202.
3
Telomerase activity and telomere lengths: alterations in renal cell carcinomas.端粒酶活性与端粒长度:肾细胞癌中的改变
Kidney Int. 1999 Oct;56(4):1289-90. doi: 10.1046/j.1523-1755.1999.00688.x.
4
Telomerase activity in human renal cell carcinoma.人肾细胞癌中的端粒酶活性
Oncogene. 1996 Jul 4;13(1):161-6.
5
The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas.通过比较基因组杂交检测到的基因畸变与人类口腔鳞状细胞癌中DNA倍性和肿瘤大小的关系。
J Oral Pathol Med. 2000 May;29(5):226-31. doi: 10.1034/j.1600-0714.2000.290506.x.
6
Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.荧光原位杂交检测的肾细胞癌染色体畸变与临床参数、DNA倍体及Ki 67表达的比较
Br J Cancer. 1998 Jun;77(11):2003-7. doi: 10.1038/bjc.1998.332.
7
Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.肾细胞癌中端粒酶活性增强、端粒长度缩短及端粒替代延长现象:可能的预测和诊断标志物
Gene. 2015 May 15;562(2):145-51. doi: 10.1016/j.gene.2015.02.079. Epub 2015 Mar 11.
8
Relation of DNA ploidy to genetic aberrations detected by chromosomal CGH and FISH in gastric adenocarcinomas.胃腺癌中DNA倍体与通过染色体比较基因组杂交(CGH)和荧光原位杂交(FISH)检测到的基因畸变的关系。
Oncol Rep. 2006 Jun;15(6):1491-6. doi: 10.3892/or.15.6.1491.
9
Telomerase activity in human renal cell carcinoma.人肾细胞癌中的端粒酶活性
Int J Urol. 2000 Jan;7(1):16-21. doi: 10.1046/j.1442-2042.2000.00130.x.
10
Telomerase activity in human urothelial tumors.人尿路上皮肿瘤中的端粒酶活性。
Am J Clin Pathol. 1997 May;107(5):555-60. doi: 10.1093/ajcp/107.5.555.

引用本文的文献

1
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.非整倍体 DNA 状态与肾细胞癌预后不良相关。
World J Urol. 2021 Mar;39(3):829-837. doi: 10.1007/s00345-020-03226-8. Epub 2020 May 2.
2
Chromosomal disruption and rearrangements during murine sarcoma development converge to stable karyotypic formation kept by telomerase overexpression.在小鼠肉瘤发展过程中,染色体破坏和重排会汇聚形成稳定的核型,这种核型由端粒酶过表达维持。
J Biomed Sci. 2016 Feb 3;23:22. doi: 10.1186/s12929-016-0230-y.
3
Laser scanning cytometry: principles and applications-an update.激光扫描细胞术:原理与应用——最新进展
Methods Mol Biol. 2013;931:187-212. doi: 10.1007/978-1-62703-056-4_11.
4
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.利用高密度单核苷酸多态性阵列对肾细胞癌染色体改变进行全基因组分析。
Int J Cancer. 2009 Nov 15;125(10):2342-8. doi: 10.1002/ijc.24642.
5
Laser scanning cytometry: principles and applications.激光扫描细胞术:原理与应用
Methods Mol Biol. 2006;319:165-92. doi: 10.1007/978-1-59259-993-6_8.
6
Telomerase activity and genetic alterations in primary breast carcinomas.原发性乳腺癌中的端粒酶活性与基因改变
Neoplasia. 2003 Mar-Apr;5(2):170-8. doi: 10.1016/s1476-5586(03)80009-x.

本文引用的文献

1
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.端粒功能障碍与小鼠和人类肠道癌的演变
Nat Genet. 2001 Jun;28(2):155-9. doi: 10.1038/88871.
2
Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.肾细胞癌中端粒酶活性及端粒酶逆转录酶表达的定量分析
Urol Res. 2001 Feb;29(1):1-6. doi: 10.1007/s002400000156.
3
Mitotic checkpoints: from yeast to cancer.有丝分裂检查点:从酵母到癌症
Curr Opin Genet Dev. 2001 Feb;11(1):83-90. doi: 10.1016/s0959-437x(00)00161-1.
4
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.端粒功能障碍会促进小鼠发生非相互易位和上皮癌。
Nature. 2000 Aug 10;406(6796):641-5. doi: 10.1038/35020592.
5
Mice without telomerase: what can they teach us about human cancer?没有端粒酶的小鼠:它们能让我们对人类癌症有哪些了解?
Nat Med. 2000 Aug;6(8):852-5. doi: 10.1038/78595.
6
Role of telomerase in normal and cancer cells.端粒酶在正常细胞和癌细胞中的作用。
J Clin Oncol. 2000 Jul;18(13):2626-34. doi: 10.1200/JCO.2000.18.13.2626.
7
Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma.采用组织微切割技术的比较基因组杂交检测的细胞遗传学异常与头颈部鳞状细胞癌激光扫描细胞术检测的DNA倍体之间的关系
Cytometry. 2000 Jun 1;40(2):161-6.
8
A critical role for telomeres in suppressing and facilitating carcinogenesis.端粒在抑制和促进癌症发生过程中起关键作用。
Curr Opin Genet Dev. 2000 Feb;10(1):39-46. doi: 10.1016/s0959-437x(99)00047-7.
9
The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers.原发性人类结直肠癌中DNA倍性与染色体不稳定性的关系。
Cancer Res. 1999 Oct 15;59(20):5283-5.
10
Telomerase activity and telomere lengths: alterations in renal cell carcinomas.端粒酶活性与端粒长度:肾细胞癌中的改变
Kidney Int. 1999 Oct;56(4):1289-90. doi: 10.1046/j.1523-1755.1999.00688.x.